Agios Pharmaceuticals, Inc. (AGIO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for AGIO. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 173 institutions reported holding AGIO, with 37.9 million shares worth $1.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 6,229,199 | $207M | DECREASED |
| Vanguard | 6,032,169 | $201M | DECREASED |
| Morgan Stanley | 3,436,589 | $114M | INCREASED |
| State Street | 3,264,652 | $109M | DECREASED |
| Assenagon Asset Management | 1,886,412 | $63M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Sarah Gheuens (Chief Medical Officer) | EXERCISE | 7,866 | $197K | 2026-10-26 |
| Sarah Gheuens (Chief Medical Officer) | SELL | 7,866 | $296K | 2026-10-26 |
| Sarah Gheuens (Chief Medical Officer) | EXERCISE | 7,866 | $197K | 2026-10-26 |
| Sarah Gheuens (Chief Medical Officer) | EXERCISE | 500 | $13K | 2026-10-22 |
| Sarah Gheuens (Chief Medical Officer) | SELL | 500 | $19K | 2026-10-22 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-08-20 |
Full institutional holdings, insider history, and congressional trades for Agios Pharmaceuticals, Inc. on SentiSense.